HealthStream, Inc. (HSTM) vs MoonLake Immunotherapeutics (MLTX)
A side-by-side comparison of HealthStream, Inc. and MoonLake Immunotherapeutics across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HSTM
HealthStream, Inc.
$31.14HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
MLTX
MoonLake Immunotherapeutics
$11.02HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — HSTM vs MLTX
growth of $100 · dividends reinvested · last 6yHSTM +50.7% (+7.1%/yr)MLTX +8.5% (+1.4%/yr)HSTM compounded faster over this window
HSTM MLTX
HSTM vs MLTX: by the numbers
- •MLTX is the larger company ($927M vs $910M market cap).
- •HSTM is profitable (6.60% net margin) while MLTX runs a net loss (0.00%).
- •HSTM pays a dividend (0.43% yield), while MLTX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | HSTM | MLTX |
|---|---|---|
| P/E ratio | 43.53 | N/A |
| Forward P/E | 42.20 | N/A |
| PEG ratio | 6.45 | N/A |
| P/S ratio | 2.83 | N/A |
| P/B ratio | 2.55 | 2.17 |
| EV / EBITDA | 12.48 | N/A |
| FCF yield | 5.37% | N/A |
Profitability
| Metric | HSTM | MLTX |
|---|---|---|
| Gross margin | 65.08% | 0.00% |
| Operating margin | 8.04% | 0.00% |
| Net margin | 6.60% | 0.00% |
| ROE | 5.94% | -61.58% |
| ROIC | 4.96% | -50.77% |
Dividends
| Metric | HSTM | MLTX |
|---|---|---|
| Dividend yield | 0.43% | N/A |
| Payout ratio | 19.01% | N/A |
Growth (annualized)
| Metric | HSTM | MLTX |
|---|---|---|
| Revenue CAGR (5Y) | 5.05% | N/A |
| EPS CAGR (5Y) | 6.75% | N/A |
| FCF CAGR (5Y) | 2.33% | N/A |
| Total return CAGR (5Y) | 2.34% | 2.81% |
Frequently asked
- Does HSTM or MLTX pay a bigger dividend?
- HSTM pays a dividend (0.43% yield), while MLTX has no payments in the available dividend history.
- Is HSTM or MLTX more profitable?
- HSTM runs the higher net margin — HSTM at 6.60% versus MLTX at 0.00%.
- How have HSTM and MLTX total returns compared?
- Over the past 5 years, HSTM delivered 2.34% and MLTX delivered 2.81% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
HealthStream P/E ratioHealthStream dividend yieldHealthStream ROEMoonLake Immunotherapeutics ROEHealthStream operating marginMoonLake Immunotherapeutics operating marginHealthStream revenue growthMoonLake Immunotherapeutics revenue growthHealthStream free cash flowMoonLake Immunotherapeutics free cash flow
HealthStream & MoonLake Immunotherapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.